|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0278 USD | -7.64% |
|
-4.14% | +6.92% |
| 05-18 | Adaptimmune Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 11-17 | Adaptimmune Therapeutics plc Announces CEO Changes | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 7.42M | - | - | - | - | - |
| 80.69B | |||||
| 51.22B | |||||
| 49.58B | |||||
| 45.5B | - | ||||
| 30.6B |
Select your edition
All financial news and data tailored to specific country editions
